A phase I trial of targeted immunotherapy with daratumumab following myeloablative total body irradiation (TBI)-based conditioning and allogeneic hematopoietic cell transplantaton in children, adolescents and young adults with high-risk T-cell acute lymphoblastic leukemia and lymphoma (T- ALL/T-LLy) (ALLO-T-DART) (IND 159396): A PTCTC facilitated study Meeting Abstract
| Authors: | Quigg, T.; Flower, A.; Teachey, D.; Lim, M.; Chu, Y.; Harrison, L.; Morris, E.; Gardenswartz, A.; Hochberg, J.; Ozkaynak, M.; Rosenblum, J.; Milner, J.; Pehlivan, K.; Levendoglu-Tugal, O.; Fabricatore, S.; Wolownik, K.; Ayello, J.; Rigot, O.; Klejmont, L.; Campbell, M.; Gonzalez, I.; Otero, N.; Budhram, A.; Mintzer, E.; Mahanti, H.; Dufresne, J.; Liu, D.; Ahmed, T.; Steinberg, A.; Sweeney, R.; McHale, P.; Islam, H.; Gerard, P.; Moorthy, C.; Voss, S.; Miles, R.; Audino, A.; Mo, X.; Stanek, J.; Olshen, A.; Hermiston, M.; Seif, A.; Cairo, M. |
| Abstract Title: | A phase I trial of targeted immunotherapy with daratumumab following myeloablative total body irradiation (TBI)-based conditioning and allogeneic hematopoietic cell transplantaton in children, adolescents and young adults with high-risk T-cell acute lymphoblastic leukemia and lymphoma (T- ALL/T-LLy) (ALLO-T-DART) (IND 159396): A PTCTC facilitated study |
| Meeting Title: | 7th International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma |
| Journal Title: | Leukemia Research |
| Volume: | 121 |
| Issue: | Suppl. |
| Meeting Dates: | 2022 Oct 20-23 |
| Meeting Location: | New York, NY |
| ISSN: | 0145-2126 |
| Publisher: | Elsevier Ltd |
| Date Published: | 2022-10-01 |
| Start Page: | S71 |
| End Page: | S73 |
| Language: | English |
| ACCESSION: | WOS:000895925500122 |
| PROVIDER: | wos |
| DOI: | 10.1016/S0145-2126(22)00315-0 |
| Notes: | Meeting Abstract: 121 -- Source: Wos |
